33
/es/
AIzaSyB4mHJ5NPEv-XzF7P6NDYXjlkCWaeKw5bc
November 1, 2025
3512562
319423
2
Create a timeline
Public Timelines
For educational institutions For teachers For students Cabinet
For educational institutions For teachers For students Open cabinet
FAQ Obtener premium
Create a timeline
Public timelines
FAQ
About & FeedbackAcuerdoPrivacidadFAQ
Support 24/7  
CabinetGet premium
Donate

1 ene 2013 año - Ado-Trastuzumab Emtansine (T-DM1)

Descripción:

For the treatment of patients with HER2-positive breast cancer previously treated with trastuzumab and/or a taxane drug, the FDA recommends ado-trastuzumab emtansine (T-DM1).

Añadido al timeline:

Cancer

ByTrinity Ozias
14 nov 2019
0
0
302

fecha:

1 ene 2013 año
Ahora mismo
~ 12 years ago
About & FeedbackAcuerdoPrivacidadFAQ
Support 24/7  
CabinetGet premium
Donate
The service accepts bank transfer (ACH, Wire) or cards (Visa, MasterCard, etc). Processed by Stripe.
Secured with SSL